- Home
- ELLO vs ABSI Comparison
ELLO vs ABSI Comparison
Compare ELLO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$3.04
Company Overview
Basic Information| Metric | ELLO | ABSI |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.8M | 357.9M |
| IPO Year | 1998 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELLO | ABSI |
|---|---|---|
| Price | $24.75 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.47 |
| AVG Volume (30 Days) | 3.2K | ★ 4.3M |
| Earning Date | 03-31-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | N/A | $631.04 |
| Revenue Next Year | N/A | $75.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.21 | $2.24 |
| 52 Week High | $30.34 | $5.23 |
Technical Indicators
Market Signals| Indicator | ELLO | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 54.72 |
| Support Level | $24.40 | $2.45 |
| Resistance Level | $25.70 | $3.27 |
| Average True Range (ATR) | 0.42 | 0.21 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 39.11 | 52.17 |
Price Performance
Historical Comparison ELLO
ABSI
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.